A Single-Centre Study of Acute Cardiorenal Syndrome: Incidence, Risk Factors and Consequences

Zehra Eren1, Olcay Ozveren, Elif Buvukoner

  • 1Department of Nephrology, Yeditepe University Hospital, Istanbul, Turkey.

Cardiorenal Medicine
|September 13, 2012
PubMed

Insights

Acute cardiorenal syndrome (CRS) is common in patients with acute decompensated heart failure (ADHF) and acute coronary syndrome (ACS). While more frequent in ADHF, CRS in ACS patients leads to higher mortality, highlighting the need for collaborative heart-kidney care.

Area of Science:

  • Cardiology
  • Nephrology
  • Critical Care Medicine

Background:

  • Cardiac and kidney diseases frequently coexist, with acute kidney injury (AKI) significantly impacting patient outcomes.
  • Acute cardiorenal syndrome (CRS) represents a complex interplay between heart and kidney dysfunction.
  • Understanding the incidence and risk factors of CRS is crucial for improving patient management.

Purpose of the Study:

  • To investigate the incidence of acute cardiorenal syndrome (CRS) in patients with acute coronary syndrome (ACS) and acute decompensated heart failure (ADHF).
  • To identify risk factors associated with the development of AKI in these patient populations.
  • To evaluate the impact of AKI on in-hospital mortality and re-admission rates.

Main Methods:

  • Retrospective cohort study of 289 patients with ACS and ADHF.
  • AKI incidence assessed using the Acute Kidney Injury Network (AKIN) classification.
  • Multivariate logistic regression and Kaplan-Meier survival analysis used to identify risk factors and outcomes.

Main Results:

  • Of 71 patients with AKI, 50.7% had ACS and 49% had ADHF.
  • Independent predictors of AKI in male ACS patients included prior myocardial infarction (>65 years), chronic kidney disease, and decreased hemoglobin.
  • Patients with ACS plus AKI exhibited significantly higher in-hospital mortality compared to those without AKI.

Conclusions:

  • Acute CRS (Type 1) is more prevalent in ADHF patients and multifactorial.
  • While less frequent in ACS, CRS is linked to increased hospital stay and mortality.
  • Collaborative management between cardiologists and nephrologists is essential for advancing CRS care and knowledge.

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
Cardiac Catheterization I: Pre-Procedure Overview01:28

Cardiac Catheterization I: Pre-Procedure Overview

Cardiac catheterization is an invasive diagnostic technique used to identify and evaluate structural and functional diseases of the heart and major blood vessels. This technique diagnoses congenital heart disease, coronary artery disease, valvular heart disease, and coronary spasms and assesses ventricular function. It helps guide treatment decisions, including the need for revascularization procedures like percutaneous coronary intervention (PCI) or coronary artery bypass grafting (CABG) and...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...